Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07498946

Comparison of Paravertebral Block and Deep Parasternal Intercostal Plane Block in Cardiac Surgery

Median sternotomy is commonly used in cardiac surgery and is often associated with significant postoperative pain. Poor pain control after sternotomy may increase opioid use, delay mobilization, prolong extubation time, and contribute to respiratory complications and longer hospital stay. Regional analgesia techniques may help improve pain management and reduce opioid requirements after surgery.

This study is a prospective, randomized, single-center clinical trial that will compare two ultrasound-guided regional analgesia techniques in adult patients undergoing elective cardiac surgery through median sternotomy: thoracic paravertebral block and bilateral deep parasternal intercostal plane block. A total of 80 patients will be randomly assigned in a 1:1 ratio to receive one of these two blocks in addition to standard general anesthesia and routine multimodal analgesia.

The main objective of the study is to compare the effects of these two techniques on total opioid consumption during the first 24 hours after surgery. Secondary outcomes include postoperative pain scores, need for additional analgesics, analgesia-related side effects such as nausea, vomiting, or respiratory depression, and extubation time. Pain will be assessed using a visual analog scale at predefined time points during the first 24 postoperative hours.

The study hypothesis is that there will be a clinically meaningful difference in postoperative analgesic effectiveness between thoracic paravertebral block and bilateral deep parasternal intercostal plane block in patients undergoing cardiac surgery via median sternotomy. The results of this study may help guide the selection of the most appropriate regional analgesia technique for pain control after sternotomy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gaziantep Şehir Hastanesi

Gaziantep, Sahinbey, Turkey (Türkiye)

About this study

Median sternotomy remains the most commonly used surgical approach in adult cardiac surgery and is associated with substantial postoperative pain. Inadequate pain control after sternotomy may lead to increased opioid consumption, delayed mobilization, prolonged extubation time, respiratory complications, and extended intensive care unit or hospital stay. Despite the routine use of multimodal analgesia, postoperative pain after sternotomy continues to be a significant clinical problem.

Ultrasound-guided regional analgesia techniques have increasingly been used as part of multimodal pain management strategies in cardiac surgery. Thoracic paravertebral block is one of the established regional techniques that can provide effective hemithoracic analgesia. However, its use may be limited by technical difficulty, dependence on operator experience, and the potential risk of complications. In contrast, deep parasternal intercostal plane block is a more superficial fascial plane block that targets the anterior cutaneous branches of the intercostal nerves, which play an important role in sternotomy-related pain. Although both techniques have shown potential benefit in previous studies, direct comparative data between thoracic paravertebral block and deep parasternal intercostal plane block are limited.

This study is designed as a prospective, randomized, controlled, single-center clinical trial in adult patients undergoing elective cardiac surgery via median sternotomy. A total of 80 patients aged 18 to 65 years with American Society of Anesthesiologists physical status II-III will be enrolled. Eligible participants who provide written informed consent will be randomly assigned in a 1:1 ratio to one of two groups: the thoracic paravertebral block group or the bilateral deep parasternal intercostal plane block group. Randomization will be performed using a computer-generated sequence, and group assignments will be concealed in sealed, opaque, sequentially numbered envelopes.

All patients will undergo surgery under standard general anesthesia and routine perioperative monitoring according to institutional practice. In addition to standard anesthesia and multimodal analgesia, patients in one group will receive ultrasound-guided thoracic paravertebral block, while patients in the other group will receive ultrasound-guided bilateral deep parasternal intercostal plane block before surgery. All block procedures will be performed by an experienced anesthesiologist. Surgical procedures will be carried out by the same cardiovascular surgical team using the standard median sternotomy technique in order to reduce procedural variability.

The primary outcome measure is total opioid consumption during the first 24 hours after surgery. Secondary outcome measures include postoperative pain scores assessed with the Visual Analog Scale at 0, 2, 4, 6, 12, and 24 hours, additional analgesic requirements, analgesia-related adverse effects such as nausea, vomiting, or respiratory depression, and extubation time. Demographic and clinical variables including age, sex, body mass index, ASA class, diabetes mellitus, comorbidities, internal mammary artery preparation, and duration of surgery will also be recorded.

The hypothesis of the study is that there will be a significant difference in postoperative analgesic effectiveness between thoracic paravertebral block and bilateral deep parasternal intercostal plane block in adult patients undergoing cardiac surgery through median sternotomy. The findings are expected to contribute to the evidence base regarding the comparative effectiveness and clinical applicability of these two active regional analgesia techniques in post-sternotomy pain management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 to 65 years Scheduled for elective cardiac surgery via median sternotomy American Society of Anesthesiologists physical status II or III Planned to undergo surgery under general anesthesia Able to comply with postoperative pain assessment using the Visual Analog Scale Able to provide written informed consent

Exclusion criteria

Emergency cardiac surgery Cardiac surgery performed through an approach other than median sternotomy Redo sternotomy Local infection or skin disruption at the planned block site Known allergy or hypersensitivity to amide local anesthetics Clinically significant coagulopathy or antiplatelet/anticoagulant treatment preventing safe regional block according to institutional protocol Clinically unstable condition or high risk for pleural complications that would make the block unsafe Chronic opioid use or chronic pain syndrome Advanced musculoskeletal disease or deformity that may interfere with pain assessment Neurological or psychiatric disorder causing inability to comply with postoperative pain assessment Cognitive impairment preventing reliable pain assessment Clinically significant peripheral neuropathy or other neurosensory condition affecting pain perception Pregnancy or breastfeeding Severe pulmonary disease, including advanced chronic obstructive pulmonary disease or severe restrictive lung disease Anticipated inability to comply with the study protocol

Treatment and study plan

Thoracic paravertebral block (TPVB)

Procedure

Ultrasound-guided thoracic paravertebral block performed before elective cardiac surgery via median sternotomy, in addition to standard general anesthesia and routine multimodal analgesia.

Bilateral Deep Parasternal Intercostal Plane Block

Procedure

Ultrasound-guided bilateral deep parasternal intercostal plane block performed before elective cardiac surgery via median sternotomy, in addition to standard general anesthesia and routine multimodal analgesia.

Primary outcomes

  1. Total Opioid Consumption in the First 24 Hours After Surgery

    Time frame: First 24 hours after surgery

    Total opioid consumption during the first 24 postoperative hours will be recorded and compared between the two groups.

Secondary outcomes

  1. Postoperative Pain Scores Assessed by Visual Analog Scale

    Time frame: 0, 2, 4, 6, 12, and 24 hours after surgery

    Postoperative pain intensity will be assessed using the Visual Analog Scale at predefined postoperative time points and compared between groups.

  2. Additional Analgesic Requirement

    Time frame: First 24 hours after surgery

    The need for rescue or additional analgesic medication during the first 24 postoperative hours will be recorded and compared between groups.

  3. Analgesia-Related Adverse Effects

    Time frame: First 24 hours after surgery

    Analgesia-related adverse effects, including nausea, vomiting, and respiratory depression, will be recorded and compared between groups.

  4. Extubation Time

    Time frame: During the postoperative period, up to 24 hours after surgery

    Time from the end of surgery to extubation will be recorded and compared between groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Burak Cemil BALIK, MD

CONTACT

[email protected]

05339545102

Sponsors and collaborators

Lead sponsor

Gaziantep City Hospital

Other

Registry information

Official study title

Comparison of Ultrasound-Guided Thoracic Paravertebral Block and Bilateral Deep Parasternal Intercostal Plane Block in Adult Patients Undergoing Elective Cardiac Surgery Via Median Sternotomy: A Prospective Randomized Controlled Trial

Acronym: SPARE-CABG

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 27, 2026
Registry last updated
Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.